About Ocelot Bio
Ocelot Bio is a company based in San Diego (United States) founded in 2020 by Gebhard Neyer and Geoff Harris. It operates as a B2B. Ocelot Bio has raised $36 million across 1 funding round from investors including RA Capital, Venrock and Vivo Capital. Ocelot Bio operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Aperiam Bio and PolyPeptide, among others.
- Headquarter San Diego, United States
- Founders Gebhard Neyer, Geoff Harris
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$36 M (USD)
in 1 rounds
-
Latest Funding Round
$36 M (USD), Series A
Apr 13, 2021
-
Investors
RA Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Ocelot Bio
Ocelot Bio has successfully raised a total of $36M through 1 strategic funding round. The most recent funding activity was a Series A round of $36 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $36.0M
-
First Round
First Round
(13 Apr 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Series A - Ocelot Bio | Valuation | Venrock , Vivo Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ocelot Bio
Ocelot Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include RA Capital, Venrock and Vivo Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location | |
|
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ocelot Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ocelot Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ocelot Bio Comparisons
Competitors of Ocelot Bio
Ocelot Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Aperiam Bio and PolyPeptide, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
|
| domain | founded_year | HQ Location |
Industrial and therapeutic proteins are manufactured by Aperiam Bio.
|
|
| domain | founded_year | HQ Location |
Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ocelot Bio
Frequently Asked Questions about Ocelot Bio
When was Ocelot Bio founded?
Ocelot Bio was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Ocelot Bio located?
Ocelot Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Ocelot Bio?
Geoff Harris is the current CEO of Ocelot Bio. They have also founded this company.
Is Ocelot Bio a funded company?
Ocelot Bio is a funded company, having raised a total of $36M across 1 funding round to date. The company's 1st funding round was a Series A of $36M, raised on Apr 13, 2021.
What does Ocelot Bio do?
Ocelot Bio operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, producing manufactured goods, and peptide production. Ocelot Bio is a CDMO specializing in peptide manufacturing services. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Who are the top competitors of Ocelot Bio?
Ocelot Bio's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
Who are Ocelot Bio's investors?
Ocelot Bio has 3 investors. Key investors include RA Capital, Venrock, and Vivo Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.